BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 37526424)

  • 1. Spontaneous episodic inflammation in the intestines of mice lacking HNF4A is driven by microbiota and associated with early life microbiota alterations.
    Kelly C; Jawahar J; Davey L; Everitt JI; Galanko JA; Anderson C; Avendano JE; McCann JR; Sartor RB; Valdivia RH; Rawls JF
    mBio; 2023 Aug; 14(4):e0150423. PubMed ID: 37526424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota.
    Garrett S; Zhang Y; Xia Y; Sun J
    Engineering (Beijing); 2024 Apr; 35():241-256. PubMed ID: 38911180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease.
    Li G; Lin J; Gao X; Su H; Lin R; Gao H; Feng Z; Wu H; Feng B; Zuo K; Li Y; Wu W; Fang L; Liu Z
    Gut Microbes; 2023 Dec; 15(2):2257269. PubMed ID: 37749885
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gaifem J; Mendes-Frias A; Wolter M; Steimle A; Garzón MJ; Ubeda C; Nobre C; González A; Pinho SS; Cunha C; Carvalho A; Castro AG; Desai MS; Rodrigues F; Silvestre R
    mBio; 2024 Apr; 15(4):e0007824. PubMed ID: 38470269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 regulates RORγt
    Liu Y; Yang M; Tang L; Wang F; Huang S; Liu S; Lei Y; Wang S; Xie Z; Wang W; Zhao X; Tang B; Yang S
    Microbiome; 2022 Jun; 10(1):98. PubMed ID: 35761415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota.
    Li N; Xu S; Zhang S; Zhu Q; Meng X; An W; Fu B; Zhong M; Yang Y; Lin Z; Liu X; Xia J; Wang J; You T; Yan C; Tang H; Zhuang G; Peng Z
    Front Immunol; 2022; 13():963379. PubMed ID: 36713428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.
    Glymenaki M; Singh G; Brass A; Warhurst G; McBain AJ; Else KJ; Cruickshank SM
    Inflamm Bowel Dis; 2017 Jun; 23(6):912-922. PubMed ID: 28498157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin profiling reveals regulatory network shifts and a protective role for hepatocyte nuclear factor 4α during colitis.
    Chahar S; Gandhi V; Yu S; Desai K; Cowper-Sal-lari R; Kim Y; Perekatt AO; Kumar N; Thackray JK; Musolf A; Kumar N; Hoffman A; Londono D; Vazquez BN; Serrano L; Shin H; Lupien M; Gao N; Verzi MP
    Mol Cell Biol; 2014 Sep; 34(17):3291-304. PubMed ID: 24980432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-37 exacerbates experimental colitis in an intestinal microbiome-dependent fashion.
    Cong J; Wu D; Dai H; Ma Y; Liao C; Li L; Ye L; Huang Z
    Theranostics; 2022; 12(11):5204-5219. PubMed ID: 35836813
    [No Abstract]   [Full Text] [Related]  

  • 11. Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis.
    Suzuki K; Yamada T; Yamazaki K; Hirota M; Ishihara N; Sakamoto M; Takahashi D; Iijima H; Hase K
    Cell Struct Funct; 2018 Mar; 43(1):25-39. PubMed ID: 29343654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.
    Chassaing B; Ley RE; Gewirtz AT
    Gastroenterology; 2014 Dec; 147(6):1363-77.e17. PubMed ID: 25172014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice.
    Howe C; Kim SJ; Mitchell J; Im E; Kim YS; Kim YS; Rhee SH
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3746-3758. PubMed ID: 30292635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
    Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
    Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.
    Schaubeck M; Clavel T; Calasan J; Lagkouvardos I; Haange SB; Jehmlich N; Basic M; Dupont A; Hornef M; von Bergen M; Bleich A; Haller D
    Gut; 2016 Feb; 65(2):225-37. PubMed ID: 25887379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.